CBD is one of at least 113 chemical compounds in the cannabis plant called cannabinoids. Unlike tetrahydrocannabinol (THC), the primary psychoactive in the herb, CBD does not cause a psychotropic “high”. The cannabis plant is capable of producing over 400 different chemical constituents. Like other herbs, cannabis is a superfood that produces a variety of compounds that can have beneficial effects in the human body. Cannabidiol (CBD) is one of these nutrients. The chemical is one of at least 113 chemical compounds in the cannabis plant called cannabinoids. A growing body of evidence suggests that cannabis has a wide array of health benefits. This includes potential uses as a general wellness and preventative aid as well as uses for pharmaceutical medicine. Since cannabinoids like CBD are produced by cannabis alone, access to the plant is extremely valuable for both personal health and wellness as well as continued pharmaceutical research. To be specific, it blocks a family of enzymes called Cytochrome P450. These enzymes are the helpers responsible for detoxing 70 to 80 percent of pharmaceutical drugs from the body. CBD, however, takes over the enzymes and prevents them from undergoing liver metabolism. This is both a blessing and a curse. The good news is that this potentially allows patients to take lower doses of their prescriptions. The bad news is that this may increase the risk of toxic buildup of pharmaceuticals in the body. In a 2015 study tested the possible interactions between the anti-anxiety and anticonvulsant drugs, clobazam and norclobazam, in 13 patients.
For years, activists have been fighting in many countries to get cannabis rescheduled or de-scheduled, so that it is no longer considered a dangerous substance. While many are still reluctant to do this, there has been some progress made on rescheduling CBD, the non-psychoactive component in cannabis. Recently, the World Health Organization ruled that CBD should no longer be considered a Schedule I drug.
According to High Times, the WHO has officially ruled that CBD is not schedule I. Their review of the substance revealed that CBD has medical value because it treats epilepsy, and that there is little potential for addiction or abuse, since it is not a psychoactive substance. As of now, they have decided that it is not worthy of scheduling at all. Another review in May 2018 will re-evaluate if it should be listed as another Schedule.
According to Network Newswire,, the offical report read, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential.” The report further indicates that, “CBD is generally well tolerated and with a good safety profile. Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications.”
This is a major step towards acceptance of cannabis worldwide, and should provide a beacon to less-accepting countries that CBD has the potential to heal, not to hurt.
Mr Jim, a 74 year old Patient with an un operable brain brain tumor and after taking our Organic infused Coconut oil,(60 mg per day) he started putting words together ... then after 3 more months he was back at the gym.
What the CBD oil did was take the swelling away.
I felt a migraine coming on and took 10 drops of Purplekyss CBD oil.... the headache never it. Now I keep my bottle in my car.
EF, Ontario, CA
Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.